• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Introduction to Tert-Butyl 4-(chloromethyl)piperidine-1-carboxylate (CAS No. 479057-79-9)

Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate, with the chemical formula C₁₁H₁₄ClNO₂, is a significant compound in the field of pharmaceutical chemistry. This compound is characterized by its tert-butyl group and the chloromethyl substituent on the piperidine ring, which makes it a versatile intermediate in the synthesis of various bioactive molecules. The CAS number 479057-79-9 uniquely identifies this substance, ensuring precise classification and handling in research and industrial applications.

The piperidine-1-carboxylate moiety in the molecular structure contributes to the compound's reactivity and its potential utility in drug development. Piperidine derivatives are widely recognized for their role in medicinal chemistry due to their ability to mimic natural amino acid structures, thereby enhancing binding affinity to biological targets. The presence of a chloromethyl group further increases the compound's synthetic value, as it can undergo nucleophilic substitution reactions to form carbon-carbon bonds, a crucial step in constructing complex molecular architectures.

In recent years, there has been growing interest in developing novel piperidine-based scaffolds for therapeutic applications. The tert-butyl group not only provides steric hindrance but also influences the electronic properties of the molecule, making it an attractive feature for designing molecules with specific pharmacokinetic profiles. Researchers have leveraged this compound in the synthesis of kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases. The ability to modify the chloromethyl group allows for further derivatization, enabling the creation of libraries of compounds for high-throughput screening.

One of the most compelling aspects of Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate is its role as a building block in peptidomimetics. Peptidomimetics are designed to mimic the bioactivity of natural peptides while avoiding their limitations, such as poor oral bioavailability and susceptibility to enzymatic degradation. The piperidine-1-carboxylate core is particularly valuable in this context because it can be linked to other functional groups to create molecules that interact with target proteins in a manner similar to peptides but with improved stability and pharmacokinetic properties.

The pharmaceutical industry has increasingly focused on developing small-molecule inhibitors that target post-translational modifications (PTMs) of proteins. PTMs play critical roles in regulating cellular processes, and their dysregulation is often associated with diseases such as cancer and neurodegenerative disorders. Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate has been utilized in the synthesis of compounds that inhibit enzymes involved in PTM pathways. For instance, it has been employed in the development of proteasome inhibitors, which are essential for managing conditions like multiple myeloma and mantle cell lymphoma.

Advances in computational chemistry have also enhanced the utility of Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate. Molecular modeling studies have revealed insights into how modifications at different positions of the piperidine ring affect binding affinity and selectivity. These studies have guided medicinal chemists in designing more effective drug candidates by predicting how changes in structure will impact biological activity. The tert-butyl group, for example, has been shown to improve solubility and metabolic stability, while the chloromethyl moiety provides a handle for further chemical transformations.

The synthesis of Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate involves multi-step organic reactions that highlight its synthetic versatility. One common approach involves the reaction of piperidine with chloroacetyl chloride followed by protection of the carboxylic acid group with an esterifying agent such as diisopropylethylamine. This method leverages nucleophilic acylation reactions, which are fundamental tools in organic synthesis. The resulting intermediate can then be further functionalized by various means, including alkylation or condensation reactions, to produce more complex derivatives.

In conclusion, Tert-butyl 4-(chloromethyl)piperidine-1-carboxylate (CAS No. 479057-79-9) is a valuable intermediate in pharmaceutical research and development. Its unique structural features, including the tert-butyl, chloromethyl, and piperidine-1-carboxylate moieties, make it a versatile building block for synthesizing bioactive molecules. Recent advancements in drug design have highlighted its importance in developing kinase inhibitors, peptidomimetics, and proteasome inhibitors. As research continues to uncover new therapeutic applications, this compound is poised to play an even greater role in addressing unmet medical needs.

• 184042-53-3(1-Piperidinecarboxylic acid, 4-(2-chloroethyl)-, 1,1-dimethylethyl ester)
• 1420901-51-4(Tert-Butyl 3-(1-chloroethyl)piperidine-1-carboxylate)
• 655224-92-3(1-Piperidinecarboxylic acid, 4-(3-chloropropyl)-, 1,1-dimethylethyl ester)
• 876589-09-2(tert-Butyl 3-(chloromethyl)piperidine-1-carboxylate)
• 1420879-53-3(Tert-Butyl 3-(2-chloroethyl)piperidine-1-carboxylate)
• 1420848-37-8(Tert-Butyl 3-(3-chloropropyl)piperidine-1-carboxylate)
• 876590-47-5(tert-butyl 2-(3-chloropropyl)piperidine-1-carboxylate)
• 1312131-48-8(Tert-butyl 4-(chloromethyl)-4-formylpiperidine-1-carboxylate)
• 1312131-45-5(4-Chloromethyl-4-hydroxymethyl-piperidine-1-carboxylic Acid tert-Butyl Ester)
• 1420811-53-5(tert-Butyl 3-(2-chloroethyl)pyrrolidine-1-carboxylate)